The FDA has elevated a recall of Inspire Medical’s nerve-stimulating implant for the treatment of obstructive sleep apnea. The agency handed down a Class I recall designation to the effort, its most ...
When people think about sleep apnea, it may not immediately elicit laughs but rather a sense of empathy. After all, losing sleep is a conundrum most people face in their lives, but for those with ...
Shares of medical-device makers ResMed Inc. and Inspire Medical Systems Inc. tumbled on Monday after Eli Lilly & Co. said it has applied for regulatory approval of its weight-loss drug Zepbound to ...
Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA ...
Inspire Medical Systems has won an expanded label from the FDA for its eponymous medical device for obstructive sleep apnea (OSA) that should expand the number of people it can be used to treat. OSA ...
Hosted on MSN
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & Supplies - Specialty Stocks In Q2
Looking back on medical devices & supplies - specialty stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Inspire Medical Systems (NYSE:INSP) and its peers. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback